Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants
Stem Cell Reports · 2025
DOI: 10.1016/j.stemcr.2024.11.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2025. Verfasst von Huijie Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section for Neurobiology, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; Danish Research Institute of Translationa…. Hauptthemen laut MEDLINE: N-Acetylglucosaminyltransferases, Intellectual Disability, Homeostasis, Acetylglucosamine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Villum Fonden, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
O-GlcNAcylation is an essential protein modification catalyzed by O-GlcNAc transferase (OGT). Missense variants in OGT are linked to a novel intellectual disability syndrome known as OGT congenital disorder of glycosylation (OGT-CDG). The mechanisms by which OGT missense variants lead to this heterogeneous syndrome are not understood, and no unified method exists for dissecting pathogenic from non-pathogenic variants. Here, we develop a double-fluorescence strategy in mouse embryonic stem cells to measure disruption of O-GlcNAc homeostasis by quantifying the effects of variants on endogenous OGT expression. OGT-CDG variants generally elicited a lower feedback response than wild-type and Genome Aggregation Database (gnomAD) OGT variants. This approach was then used to dissect new putative OGT-CDG variants from pathogenic background variants in other disease-associated genes. Our work enables the prediction of pathogenicity for rapidly emerging de novo OGT-CDG variants and points to reduced disruption of O-GlcNAc homeostasis as a common mechanism underpinning OGT-CDG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section for Neurobiology, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; Danish Research Institute of Translational Neuroscience DANDRITE-Nordic EMBL Partnership for Molecular Medicine…
- Section for Neurobiology, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
- Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
- Joe DiMaggio Children's Hospital, Hollywood, FL, USA.
- Department of Clinical Genomics, Mayo Clinic, Rochester, NY, USA.
Förderung
- Novo Nordisk Fonden
- Villum Fonden
- Biotechnology and Biological Sciences Research Council
- China Scholarship Council
- Wellcome Trust
Zitieren
APA
Yuan, H., Mitchell, C. W., Ferenbach, A. T., Bonati, M. T., Feresin, A., Benke, P. J., Tan, Q. K. G., & van Aalten, D. M. F. (2025). Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2024.11.010
Vancouver
Yuan H, Mitchell CW, Ferenbach AT, Bonati MT, Feresin A, Benke PJ, et al. Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants. Stem Cell Reports. 2025. doi:10.1016/j.stemcr.2024.11.010
BibTeX
@article{Yuan2025,
author = {Yuan, Huijie and Mitchell, Conor W and Ferenbach, Andrew T and Bonati, Maria Teresa and Feresin, Agnese and Benke, Paul J and Tan, Queenie K G and van Aalten, Daan M F},
title = {Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants},
journal = {Stem Cell Reports},
year = {2025},
doi = {10.1016/j.stemcr.2024.11.010}
}
EUVIMED